Eikon Therapeutics is a biopharmaceutical company. It engages in the development of medicines for unmet medical needs. The company was founded in 2019 and is headquartered in Millbrae, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Eikon Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Eikon Therapeutics Inc. market cap is $814.21M.
What is the 52-week high for Eikon Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Eikon Therapeutics Inc. 52 week high is $18.00 as of February 15, 2026.
What is the 52-week low for Eikon Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Eikon Therapeutics Inc. 52 week low is $13.29 as of February 15, 2026.
What is Eikon Therapeutics Inc. stock price today?
Eikon Therapeutics Inc. stock price today is $15.05.
What was Eikon Therapeutics Inc. stock price yesterday?
Eikon Therapeutics Inc. stock price yesterday was $14.83.
What is the Price-to-Book ratio of Eikon Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Eikon Therapeutics Inc. P/B ratio is -1.3277.
What is the 50-day moving average of Eikon Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Eikon Therapeutics Inc. 50-day moving average is $15.00.